↓ Skip to main content

Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation

Overview of attention for article published in Frontiers in Pharmacology, February 2024
Altmetric Badge

Mentioned by

twitter
1 X user